Understanding the Significance of Hypoxia-Inducible Factors (HIFs) in Glioblastoma: A Systematic Review
Simple Summary This study explores hypoxia-inducible factors (HIFs) in glioblastoma
development, progression, and treatment. Reviewing 104 relevant studies, it highlights …
development, progression, and treatment. Reviewing 104 relevant studies, it highlights …
[HTML][HTML] The landscape of circRNAs in gliomas temozolomide resistance: Insights into molecular pathways
A Mafi, N Hedayati, S Kahkesh, S Khoshayand… - Non-coding RNA …, 2024 - Elsevier
As the deadliest type of primary brain tumor, gliomas represent a significant worldwide
health concern. Circular RNA (circRNA), a unique non-coding RNA molecule, seems to be …
health concern. Circular RNA (circRNA), a unique non-coding RNA molecule, seems to be …
Prospects of marine-derived compounds as potential therapeutic agents for glioma
Y Liu, Z Zhou, S Sun - Pharmaceutical Biology, 2024 - Taylor & Francis
Context Glioma, the most common primary malignant brain tumour, is a grave health
concern associated with high morbidity and mortality. Current treatments, while effective to …
concern associated with high morbidity and mortality. Current treatments, while effective to …
Unlocking Novel Therapeutic Avenues in Glioblastoma: Harnessing 4-amino Cyanine and miRNA Synergy for Next-Gen Treatment Convergence
K Sandhanam, T Tamilanban, K Manasa… - Neuroscience, 2024 - Elsevier
Glioblastoma (GBM) poses a formidable challenge in oncology due to its aggressive nature
and dismal prognosis, with average survival rates around 15 months despite conventional …
and dismal prognosis, with average survival rates around 15 months despite conventional …
Revolutionizing Brain Tumor Care: Emerging Technologies and Strategies
Glioblastoma multiforme (GBM) is one of the most aggressive forms of brain tumor,
characterized by a daunting prognosis with a life expectancy hovering around 12–16 …
characterized by a daunting prognosis with a life expectancy hovering around 12–16 …
APTAMERS: USHERING IN NEW HOPES IN TARGETED GLIOBLASTOMA THERAPY
D Chatterjee, S Bhattacharya, L Kumari… - Journal of Drug …, 2024 - Taylor & Francis
Glioblastoma, a formidable brain cancer, has remained a therapeutic challenge due to its
aggressive nature and resistance to conventional treatments. Recent data indicate that …
aggressive nature and resistance to conventional treatments. Recent data indicate that …
Evaluation of Microvascular Density in Glioblastomas in Relation to p53 and Ki67 Immunoexpression
Glioblastoma is the most aggressive tumor in the central nervous system, with a survival rate
of less than 15 months despite multimodal therapy. Tumor recurrence frequently occurs after …
of less than 15 months despite multimodal therapy. Tumor recurrence frequently occurs after …
Ferroptosis in glioma therapy: advancements in sensitizing strategies and the complex tumor-promoting roles
SY Kim, M Tang, T Lu, SY Chih, W Li - Brain Research, 2024 - Elsevier
Ferroptosis, an iron-dependent form of non-apoptotic regulated cell death, is induced by the
accumulation of lipid peroxides on cellular membranes. Over the past decade, ferroptosis …
accumulation of lipid peroxides on cellular membranes. Over the past decade, ferroptosis …